DOI: 10.1055/s-00000025

Hormone and Metabolic Research

References

Fassnacht M, Berruti A, Baudin E. et al.
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: A double-blind, randomised, phase 3 study.

Lancet Oncol 2015;
16: 426-435

Download Bibliographical Data

Access:
Access: